226.48BMarket Cap32.47P/E (TTM)
75.120High72.620Low6.08MVolume75.050Open74.090Pre Close446.20MTurnover0.20%Turnover Ratio32.47P/E (Static)3.10BShares86.44052wk High5.55P/B225.60BFloat Cap61.86652wk Low1.49Dividend TTM3.09BShs Float86.440Historical High2.03%Div YieldTTM3.37%Amplitude5.297Historical Low73.439Avg Price1Lot Size
AstraZeneca Stock Forum
ENHERTU Shows 38% Reduced Death Risk in Breast Cancer - EU Approval Now One Step Closer
Can This Breakthrough Breast Cancer Drug Transform AstraZeneca's Oncology Portfolio?
Global Healthcare Revolution: Elite Hospitals Rush to Implement This Game-Changing Cancer Test
Breakthrough in Bladder Cancer Treatment: AstraZeneca's IMFINZI Slashes Disease Progression Risk by 42%
Groundbreaking Digital Adventure Helps Kids Master Their Rare Kidney Disease Journey
Major Breakthrough: AstraZeneca's New Weapon Against Early-Stage Lung Cancer Enters Final Testing
Off topic here a bit however I found this intriguing that Cobas was introduced in '94 however Roche only started divi...
Multiple sources indicate that Esperion's advancements and commercial success with its cholesterol-lowering drugs, NEXLIZET and NEXLETOL, Esperion has positioned itself as an acquisition target for larger pharmaceutical compa...
No comment yet